vTv Therapeutics to Present at the 30th Annual Piper Jaffray Healthcare Conference
November 19 2018 - 4:00PM
Business Wire
vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that
company management will present a corporate overview at the Piper
Jaffray 30th Annual Healthcare Conference on Tuesday, Nov. 27, 2018
at 2:10 p.m. ET in New York City.
A live webcast of the presentation can be
accessed here and will be archived for 30 days following
the presentation at www.vtvtherapeutics.com.
vTv Therapeutics is a clinical-stage biopharmaceutical company
engaged in the discovery and development of orally administered
small molecule drug candidates to fill significant unmet medical
needs. vTv has a pipeline of clinical drug candidates led by
programs for the treatment of Alzheimer’s disease and diabetes as
well as treatment of inflammatory disorders.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181119005483/en/
Investors:vTv Therapeutics
Inc.IR@vtvtherapeutics.comorMedia:Josh
Vlasto212-572-5969PR@vtvtherapeutics.com
vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From Mar 2024 to Apr 2024
vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From Apr 2023 to Apr 2024